---
title: "Pharmacist-Led Medication Titration for Cardiometabolic Disease: Evidence and Scale"
id: "pubmed-42928327"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42928327"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42928327/"
doi: "10.1007/s11886-026-02432-x"
published_at: "2026-10-26T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Pharmacist-Led Medication Titration for Cardiometabolic Disease: Evidence and Scale
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42928327
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42928327/)
- **DOI:** [10.1007/s11886-026-02432-x](https://doi.org/10.1007%2Fs11886-026-02432-x)
- **Published At:** 2026-10-26T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The review examined community-based **pharmacist-led** medication titration across multiple **cardiometabolic** conditions, positioning interventions along a continuum from passive identification to active longitudinal management. - Investigators reported that registries, dashboards, audit-and-feedback, EHR alerts, and inpatient initiation can identify undertreatment but do not provide infrastructure for dose adjustment, monitoring, adherence support, or medication-access navigation. - The strongest published evidence exists for **hypertension**, where pharmacist-led programs produced meaningful blood pressure reductions in community and team-based models. - For **heart failure**, the authors noted that interdisciplinary titration programs address target-dose achievement more directly than alerts or decision-support tools. - Emerging data extend pharmacist-led titration to **diabetes**, **lipidology**, and **obesity**, though the review described these areas as developing rather than definitively established. - The review framed value-based payment as a possible reimbursement framework to support scale; however, authors reported that broad implementation requires equity-focused deployment, flexible staffing, population-health infrastructure linking **artificial intelligence-enabled patient identification** to action, and sustainable reimbursement. - Limitations identified in the review include the need for infrastructure to enable monitoring and follow-up and the absence of a single scalable model; the authors called for implementation strategies centered on equity and connectivity rather than listing new trial data.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42928327/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42928327/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42928327/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42928327/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42928327/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42928327/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42928327/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42928327/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42928327/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42928327/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42928327/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42928327/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42928327/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42928327/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42928327/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42928327/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42928327/#mesh-terms) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Review Curr Cardiol Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Cardiol+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Cardiol+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) . 2026 Oct 26;28(1):117. doi: 10.1007/s11886-026-02432-x. # Pharmacist-Led Medication Titration for Cardiometabolic Disease: Evidence, Equity, and Scale [Siddharth Yarlagadda](https://pubmed.ncbi.nlm.nih.gov/?term=Yarlagadda+S&cauthor_id=42928327)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#full-view-affiliation-1 "Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#full-view-affiliation-2 "Harvard Medical School, Boston, MA, USA."), [Alexander J Blood](https://pubmed.ncbi.nlm.nih.gov/?term=Blood+AJ&cauthor_id=42928327)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#full-view-affiliation-3 "Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. ablood3@mgb.org.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#full-view-affiliation-4 "Harvard Medical School, Boston, MA, USA. ablood3@mgb.org.") Affiliations Expand ### Affiliations * 1 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. * 2 Harvard Medical School, Boston, MA, USA. * 3 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. ablood3@mgb.org. * 4 Harvard Medical School, Boston, MA, USA. ablood3@mgb.org. * PMID: **42928327** * DOI: [ 10.1007/s11886-026-02432-x ](https://doi.org/10.1007/s11886-026-02432-x) Item in Clipboard Review # Pharmacist-Led Medication Titration for Cardiometabolic Disease: Evidence, Equity, and Scale Siddharth Yarlagadda et al. Curr Cardiol Rep. 2026. Show details Display options Display options Format Abstract PubMed PMID Curr Cardiol Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Cardiol+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Cardiol+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) . 2026 Oct 26;28(1):117. doi: 10.1007/s11886-026-02432-x. ### Authors [Siddharth Yarlagadda](https://pubmed.ncbi.nlm.nih.gov/?term=Yarlagadda+S&cauthor_id=42928327)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#short-view-affiliation-1 "Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#short-view-affiliation-2 "Harvard Medical School, Boston, MA, USA."), [Alexander J Blood](https://pubmed.ncbi.nlm.nih.gov/?term=Blood+AJ&cauthor_id=42928327)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#short-view-affiliation-3 "Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. ablood3@mgb.org.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42928327/#short-view-affiliation-4 "Harvard Medical School, Boston, MA, USA. ablood3@mgb.org.") ### Affiliations * 1 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. * 2 Harvard Medical School, Boston, MA, USA. * 3 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. ablood3@mgb.org. * 4 Harvard Medical School, Boston, MA, USA. ablood3@mgb.org. * PMID: **42928327** * DOI: [ 10.1007/s11886-026-02432-x ](https://doi.org/10.1007/s11886-026-02432-x) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Purpose of review:** To review community-based pharmacist-led medication titration across cardiometabolic conditions and the infrastructure needed to deliver this model at scale. **Recent findings:** This review reframes cardiometabolic medication optimization as a continuum from passive gap identification to active longitudinal medication management. Registries, dashboards, audit and feedback, electronic health record alerts, and inpatient initiation can identify undertreatment or prompt prescribing, but they do not provide infrastructure for dose adjustment, monitoring, adherence support, and medication-access navigation. Pharmacist-led, team-based models occupy the active end of this continuum. The strongest evidence is in hypertension, with meaningful blood pressure reductions; in heart failure, interdisciplinary titration programs more directly address target-dose achievement than alerts or decision-support tools. Emerging data extend this framework to diabetes, lipidology, and obesity. Value-based care provides a reimbursement framework to support these services. Pharmacist-led titration can close gaps between therapies and delivery, but scaling requires equity-focused implementation, flexible staffing, population health infrastructure that connects artificial intelligence-enabled patient identification to action, and sustainable reimbursement. **Keywords:** Artificial Intelligence-Enabled Patient Identification; Cardiometabolic Disease; Medication Titration; Pharmacist-Led Care; Population Health; Value-Based Care. © 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Human and Animal Rights and Informed Consent: No animal or human subjects by the authors were used in this study. Competing interests: S.Y. declares no competing interests. A.J.B. discloses Grants: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly, General Electric Health, Merck; Consulting: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Corcept Therapeutics, Milestone Therapeutics, NODE Health, Alnylam Pharma, Color Health, Medscape, Nference Inc., Walgreens Health, Withings, HelloHeart; Equity: AIwithCare, Knownwell Health, Porter Health, Nference; Payment or Honoraria: McMaster University, Geisinger Health, Medscape; Support for attending meetings and/or travel: American Heart Association; Patents: Retrieval-augmented generation for medical data (pending). Use of Artificial Intelligence: AI tools were used to assist with language and grammar editing, organization of source notes, and management of source-derived information during manuscript preparation. The authors independently determined the article structure, selected all cited sources, and chose the information extracted from each source. AI was not used to independently analyze or interpret data, create figures or tables, or draw scientific conclusions. All content was reviewed, edited, and approved by the authors, who take full responsibility for the final manuscript. ## References 1. 1. Palaniappan LP et al. Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2026;153(9). . 2. 1. Kazi DS, et al. Forecasting the Economic Burden of CVD and Stroke Through 2050. Circulation. 2024;150(4):e89–101. . - [DOI](https://doi.org/10.1161/cir.0000000000001258) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/38832515/) 3. 1. Joynt Maddox KE, et al. Forecasting the Burden of CVD and Stroke Through 2050-Prevalence. Circulation. 2024;150(4):e65–88. . - [DOI](https://doi.org/10.1161/cir.0000000000001256) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/38832505/) 4. 1. Writing Committee Members, Ndumele CE, Rodriguez F, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026. . - [DOI](https://doi.org/10.1161/cir.0000000000001453) 5. 1. Greene SJ, et al. Medical Therapy for HFrEF: The CHAMP-HF Registry. J Am Coll Cardiol. 2018;72(4):351–66. . - [DOI](https://doi.org/10.1016/j.jacc.2018.04.070) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/30025570/) Show all 86 references ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) ## MeSH terms * Cardiovascular Diseases* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cardiovascular+Diseases%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cardiovascular+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Diabetes Mellitus / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2Fdrug+therapy%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Heart Failure / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Heart+Failure%2Fdrug+therapy%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Heart+Failure) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Hypertension / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypertension%2Fdrug+therapy%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hypertension) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Pharmacists* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pharmacists%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pharmacists) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Professional Role Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Professional+Role%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Professional+Role) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) * Value-Based Health Care Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Value-Based+Health+Care%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Value-Based+Health+Care) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42928327/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/42928327/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/42928327/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42928327%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/42928327/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.
## Related Clinical Research

- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [GLP-1 drugs tied to lower diabetes progression and cardiovascular events than metformin](https://medichelpline.com/clinical-feed/aha-news-4-glp-1-meds-linked-to-lower-diabetes-heart-risks-than-standard-diabetes.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [AI Model Flags Patients at Risk for Underdiagnosed Primary Aldosteronism](https://medichelpline.com/clinical-feed/endocrine-news-1-video-ai-model-identifies-patients-at-risk-of-underdiagnosed-cause-of-high.md)
- [Stroke and Ischemic Heart Disease Trends in Western Sub‑Saharan Africa vs Global Progress, 1990–20](https://medichelpline.com/clinical-feed/medrxiv-0-divergent-trends-in-stroke-and-ischemic-heart-disease-mortality-and-disability.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.